Aligarh, India

Mohammed Salman Hashmi

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Ranbaxy Laboratories, Inc., Sun Pharmaceutical Industries Limited. Active years: 2013-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohammed Salman Hashmi. Retrieved from https://idiyas.com/inventor/mohammed-salman-hashmi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mohammed Salman Hashmi: Pharmaceutical Process Inventor

Introduction

Mohammed Salman Hashmi is an inventor associated with Aligarh, India. His patent work focuses on processes for preparing pharmaceutical compounds and their intermediates. He is credited with 2 patents.

Latest Patents

Hashmi’s listed patents include “Process for the Preparation of Tofacitinib and Intermediates Thereof.” The invention describes compounds of Formula III and Formula VI, methods for preparing them, and their use in producing tofacitinib, its isomers or mixtures of isomers, and their salts.

His other listed patent is “Process for the Preparation of Valganciclovir Hydrochloride.” It presents a process for preparing pure valganciclovir hydrochloride.

Career Highlights

Hashmi has been associated with Sun Pharmaceutical Industries Limited and Ranbaxy Laboratories, Inc. His patent work reflects a focus on pharmaceutical manufacturing processes and the preparation of active compounds.

Collaborations

His listed coworkers include Chandra Has Khanduri and Mukesh Kumar Sharma.

Conclusion

Mohammed Salman Hashmi’s two patents address processes for preparing tofacitinib and valganciclovir hydrochloride, highlighting his contributions to pharmaceutical process development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…